metolazone has been researched along with Obesity in 2 studies
Metolazone: A quinazoline-sulfonamide derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
metolazone : A quinazoline that consists of 1,2,3,4-tetrahydroquinazolin-4-one bearing additional methyl, 2-tolyl, sulfamyl and chloro substituents at positions 2, 3, 6 and 7 respectively. A quinazoline diuretic, with properties similar to thiazide diuretics.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arosio, E | 1 |
Pancera, P | 1 |
Apolloni, E | 1 |
Covi, G | 1 |
Lechi, A | 1 |
Truniger, B | 1 |
2 other studies available for metolazone and Obesity
Article | Year |
---|---|
[Clinical evaluation of metolazone in edematogenic syndromes].
Topics: Adult; Aged; Coronary Disease; Diuretics; Edema; Female; Heart Failure; Heart Valve Diseases; Humans | 1984 |
[Therapy edema: secondary effect without effect!].
Topics: Adult; Anuria; Diuretics; Edema; Female; Furosemide; Humans; Lymphedema; Metolazone; Obesity | 1999 |